Connection

GIULIANA J IZZO to Humans

This is a "connection" page, showing publications GIULIANA J IZZO has written about Humans.
Connection Strength

0.117
  1. From Uniplex to Multiplex Molecular Profiling in Advanced Non-Small Cell Lung Carcinoma. Cancer J. 2015 Sep-Oct; 21(5):413-24.
    View in: PubMed
    Score: 0.010
  2. Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation. Cancer. 2012 Sep 01; 118(17):4346-53.
    View in: PubMed
    Score: 0.008
  3. Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation. Dis Esophagus. 2009; 22(2):127-32.
    View in: PubMed
    Score: 0.006
  4. Thinking in and out of the box when it comes to gastric cancer and cyclooxygenase-2. J Clin Oncol. 2007 Nov 01; 25(31):4865-7.
    View in: PubMed
    Score: 0.006
  5. Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression. Cancer Epidemiol Biomarkers Prev. 2007 Jun; 16(6):1200-5.
    View in: PubMed
    Score: 0.006
  6. Molecular mechanisms in Barrett's metaplasia and its progression. Semin Oncol. 2007 Apr; 34(2 Suppl 1):S2-6.
    View in: PubMed
    Score: 0.006
  7. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma. J Clin Oncol. 2007 Feb 20; 25(6):698-707.
    View in: PubMed
    Score: 0.006
  8. Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma. Mol Cancer Ther. 2006 Nov; 5(11):2844-50.
    View in: PubMed
    Score: 0.005
  9. Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol. 2006 Feb 10; 24(5):748-54.
    View in: PubMed
    Score: 0.005
  10. Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis. Semin Oncol. 2005 Dec; 32(6 Suppl 9):S11-5.
    View in: PubMed
    Score: 0.005
  11. Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. J Natl Cancer Inst. 2003 Feb 05; 95(3):198-205.
    View in: PubMed
    Score: 0.004
  12. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene. 1998 Nov 05; 17(18):2313-22.
    View in: PubMed
    Score: 0.003
  13. Detection of RAS mutation by pyrosequencing in thyroid cytology samples. Int J Surg. 2014; 12 Suppl 1:S91-4.
    View in: PubMed
    Score: 0.002
  14. FXR silencing in human colon cancer by DNA methylation and KRAS signaling. Am J Physiol Gastrointest Liver Physiol. 2014 Jan 01; 306(1):G48-58.
    View in: PubMed
    Score: 0.002
  15. Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer. Cancer Res. 2013 Jun 01; 73(11):3235-47.
    View in: PubMed
    Score: 0.002
  16. The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell. 2012 Mar 20; 21(3):374-87.
    View in: PubMed
    Score: 0.002
  17. The current and future place of vinorelbine in cancer therapy. Drugs. 1992; 44 Suppl 4:36-45; discussion 66-9.
    View in: PubMed
    Score: 0.002
  18. Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS One. 2010 Nov 30; 5(11):e15074.
    View in: PubMed
    Score: 0.002
  19. Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer. Cancer Prev Res (Phila). 2010 Oct; 3(10):1235-45.
    View in: PubMed
    Score: 0.002
  20. Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol. Antioxid Redox Signal. 2009 May; 11(5):1083-95.
    View in: PubMed
    Score: 0.002
  21. Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation. Dig Dis Sci. 2010 Apr; 55(4):1098-105.
    View in: PubMed
    Score: 0.002
  22. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res (Phila). 2009 May; 2(5):459-65.
    View in: PubMed
    Score: 0.002
  23. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis. 2009 May; 30(5):785-92.
    View in: PubMed
    Score: 0.002
  24. Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. J Clin Oncol. 2009 Feb 20; 27(6):857-71.
    View in: PubMed
    Score: 0.002
  25. Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res (Phila). 2009 Jan; 2(1):14-21.
    View in: PubMed
    Score: 0.002
  26. Chemotherapy and radiotherapy resistance: complexity, reality, and promise. J Clin Oncol. 2009 Jan 01; 27(1):162-3; author reply 163.
    View in: PubMed
    Score: 0.002
  27. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. Cancer. 2008 Sep 15; 113(6):1302-8.
    View in: PubMed
    Score: 0.002
  28. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res. 2008 Apr 15; 68(8):2632-40.
    View in: PubMed
    Score: 0.002
  29. Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer. Cancer. 2007 Sep 01; 110(5):989-95.
    View in: PubMed
    Score: 0.001
  30. Targeting the hedgehog pathway to mitigate treatment resistance. Cell Cycle. 2007 Aug 01; 6(15):1826-30.
    View in: PubMed
    Score: 0.001
  31. Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport. Oncogene. 2007 Aug 16; 26(38):5674-9.
    View in: PubMed
    Score: 0.001
  32. Decreased expression of gene cluster at chromosome 1q21 defines molecular subgroups of chemoradiotherapy response in esophageal cancers. Clin Cancer Res. 2007 Feb 01; 13(3):912-9.
    View in: PubMed
    Score: 0.001
  33. Biomarkers of response to preoperative chemoradiation in esophageal cancers. Semin Oncol. 2006 Dec; 33(6 Suppl 11):S2-5.
    View in: PubMed
    Score: 0.001
  34. Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res. 2006 Nov 01; 12(21):6565-72.
    View in: PubMed
    Score: 0.001
  35. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol. 2006 Jan 10; 24(2):259-67.
    View in: PubMed
    Score: 0.001
  36. AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells. Cancer Genet Cytogenet. 2005 May; 159(1):10-7.
    View in: PubMed
    Score: 0.001
  37. Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis. Cancer. 2005 Mar 01; 103(5):952-9.
    View in: PubMed
    Score: 0.001
  38. Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development. Clin Cancer Res. 2001 Oct; 7(10):3127-34.
    View in: PubMed
    Score: 0.001
  39. [Biomarkers of carcinogenesis of the upper and lower airway epithelium and the role of chemoprevention]. Bull Cancer. 2001 Apr; 88(4):351-61.
    View in: PubMed
    Score: 0.001
  40. Characterization and drug sensitivity of four newly established colon adenocarcinoma cell lines to antifolate inhibitors of thymidylate synthase. Oncol Res. 2001; 12(8):309-14.
    View in: PubMed
    Score: 0.001
  41. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer. Clin Cancer Res. 1998 Mar; 4(3):539-44.
    View in: PubMed
    Score: 0.001
  42. Pretreatment of colon carcinoma cells with Tomudex enhances 5-fluorouracil cytotoxicity. Clin Cancer Res. 1998 Feb; 4(2):469-73.
    View in: PubMed
    Score: 0.001
  43. Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene. 1997 Apr 17; 14(15):1799-803.
    View in: PubMed
    Score: 0.001
  44. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver. J Nucl Med. 1996 Apr; 37(4 Suppl):29S-32S.
    View in: PubMed
    Score: 0.001
  45. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer. J Clin Oncol. 1994 Oct; 12(10):2102-12.
    View in: PubMed
    Score: 0.001
  46. A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer. Cancer. 1990 Aug 15; 66(4):640-4.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.